President, MedaPhase, Inc.; Managing Partner, Newnan Dermatology
Dermatology
Dr. Mark R. Ling, MD
|
|
Give Review
Mark Ling practices Dermatology. He graduated from Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Mark Ling is a published physician as well. He has 22 publications published. The latest was: Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for Actinic keratosis.
- Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic Dermatitis: a phase III trial.
- Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures i...
- Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple Actinic keratoses of the face and scalp: investigato...
- Acitretin: optimal dosing strategies.
- Tacrolimus ointment for the treatment of Atopic dermatitis is not associated with an increase in cutaneous infections.
- Dermatologic drug formulary: an American Academy of Dermatology white paper.
- Effective treatment of Actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
- A randomized trial of etanercept as monotherapy for Psoriasis.
- Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingerNail.
- Tacrolimus ointment for the treatment of Atopic dermatitis in adult patients: part I, efficacy.
- Dapsone gel 5% for the treatment of Acne vulgaris: safety and efficacy of long-term (1 year) treatment.
- Clinical evidence for the role of a topical anti-inflammatory agent in comedonal Acne: findings from a randomized study of dapsone gel 5% in combination with tazaroten...
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingerNail.
- Dosing with 5% imiquimod cream 3 times per week for the treatment of Actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-contr...
- Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for Actinic keratoses on the head.
- A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with Atopic dermatitis.
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toeNail.
- Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular Acne.
- Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque Psoriasis.
- Pimecrolimus cream 1% in the treatment of intertriginous Psoriasis: a double-blind, randomized study.
Schools
Duke University
University Of Pennsylvania
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- Excision of Malignant Skin Lesion
- View All
Conditions Treated
- Acanthosis Nigricans
- Acne
- Actinic Keratosis
- Athlete's Foot
- View All
Doctors Specialties
- Dermatology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
University of Pennsylvania Health System -
Duke University School of Medicine
Hospital
-
Piedmont Hospital
Drug Facts
| NPI NUMBER | 1639153638 | |
| NPPES Provider LastName | LING | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 302632321 | |
| NPPES Provider State | GA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 2316.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639153638 |
| Last Name Of The Provider | LING |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Andrew T. McDonald, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Stanley W. Smith, MD |
|
|
Dr. Anuradha Guthikonda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Buckley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin E. Woods, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garin D. Barth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark J. Holzberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Marcet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita K. Shetty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Malik M. Merchant, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Metts, MD |